key: cord-0012666-a98j13rz
authors: Fernández, Rogelio; Bayu, Asep; Aryono Hadi, Tri; Bueno, Santiago; Pérez, Marta; Cuevas, Carmen; Yunovilsa Putra, Masteria
title: Unique Polyhalogenated Peptides from the Marine Sponge Ircinia sp.
date: 2020-07-28
journal: Mar Drugs
DOI: 10.3390/md18080396
sha: b645eaf8d2a1e9b0e3775c237cb11e3daf04e60a
doc_id: 12666
cord_uid: a98j13rz

Two new bromopyrrole peptides, haloirciniamide A (1) and seribunamide A (2), have been isolated from an Indonesian marine sponge of the genus Ircinia collected in the Thousand Islands (Indonesia). The planar structure of both compounds was assigned on the basis of extensive 1D and 2D NMR spectroscopy and mass spectrometry. The absolute configuration of the amino acid residues in 1 and 2 was determined by the application of Marfey’s method. Compound 1 is the first dibromopyrrole cyclopeptide having a chlorohistidine ring, while compound 2 is a rare peptide possessing a tribromopyrrole ring. Both compounds failed to show significant cytotoxicity against four human tumor cell lines, and neither compound was able to inhibit the enzyme topoisomerase I or impair the interaction between programmed cell death protein PD1 and its ligand, PDL1.

Indonesia is located at the center of a biodiversity hotspot, and around 750 structures from Indonesian waters have been published in the last 50 years [1] . The structural diversity and bioactive properties of the compounds isolated from this region encouraged us to continue to investigate this area, which still remains largely unexplored. Thus, one of the recent PharmaMar expeditions was carried out in the Thousand Islands, in collaboration with Indonesian Institute of Sciences (LIPI). The Thousand Islands archipelago is located about 25 miles from the coast to the northeast of Jakarta; the collection site is an area full of gentle rock and coral slopes, and it is potentially a highly productive area, both in terms of the quantity and the nature of the biodiversity. In this paper, we describe the isolation of two new peptides isolated from an Ircinia specimen from this area.

Of all the marine organisms investigated, sponges (Porifera) are the most primitive multicellular animals with ample time to evolve into more complex living organisms. In fact, marine sponges are recognized as the richest sources of MNP, contributing to nearly 30% of all marine natural products discovered so far [2] . Previous reports revealed that Marine sponges of the genus Ircinia are known as a rich source of varied bioactive natural products, including fatty acids [3] , steroids [4, 5] , terpenes [6, 7] , macrolides [8, 9] , and peptides [10] , many of which have biological activities. This structural diversity could be due to the fact that sponges harbor diverse microorganisms and in numerous cases, bacteria isolated from sponges or symbiotic bacteria are the true producers of the compounds found in their extracts [11] . Specifically, an intriguing group of Ircinia-derived peptides are assumed to be of microbial origin due to the presence of both d-amino acids and unusual amino acids, as illustrated by the cyclic hexapeptide waiakeamide from Ircinia dendroides [12] and the cyclotheonamides E4 and E5, which are cyclic pentapeptides also from Ircinia species [13] .

Undeniably, among the compounds isolated from marine sources, linear and cyclic peptides are recognized as an important class with great structural diversity and a wide range of bioactivities, and these include the antimalarial carmabin A [14] , the antiproliferative jaspamides [15] , and the cytotoxic patellamides [16] . Furthermore, two marine peptide-derived products have reached the market: ziconotide [17] for analgesic use and a synthetic derivative of dolastatin 10 [18] linked to an antibody for the treatment of Hodgkin's lymphoma. PharmaMar has also developed a marine natural peptide Aplidin, which was originally found in the Ascidian Aplidium albicans and has recently been approved for commercialization in Australia for the treatment of multiple myeloma. Recent studies suggest that Aplidin may also have antiviral properties, and a clinical trial to treat patients with COVID-19 has been initiated.

In the course of our screening program to isolate novel compounds with antitumor properties from marine sources, the organic extract of an Ircinia specimen collected off the coast of the Thousand Islands showed hints of activity, and although the fractions did not confirm cytotoxicity, the chromatographic profiles along with the mass spectra showed peaks that were interesting enough for us to purify them. Thus, we have isolated two unique peptides haloirciniamide A (1) and seribunamide A (2). It is worth mentioning that the number of known peptides with a halogenated pyrrole ring is limited, with only cyclocinamides and corticiamide A [19] as well as gunungamide A [20] having been described as possessing chlorinated pyrrole rings. Although there are dozens of dibromopyrrolecarboxamide derivatives from porifera such as nagelamide [21] and carteramine [22] , mainly from Agela and Stylissa species, compound 1 is the first example of a peptide containing a halogenated pyrrole ring in its structure. Indeed, haloirciniamide A represents a structurally unique cyclopeptide, since it also has an unprecedented chlorohistidine moiety. Furthermore, there are only two examples of tribromopyrrole rings derived from natural sources: 2,3,4-tribromopyrrole itself, which was isolated from the marine Poychaete Polyphysia crassa [23] , and tribromopyrrol-2-methylphenol isolated from a coralline algal-associated Pseudoalteromone [24] , with compound 2 being the first of its class.

Details of the isolation and structural elucidation of the new halogenated peptides 1 and 2 are provided. The results of cytotoxicity and other related antitumor programmed cell death protein (PD1) and TOPO-I screenings are also described.

The sponge Ircinia sp. was collected by hand while diving in the Thousand Islands (Indonesia). The specimen was repeatedly extracted using CH 2 Cl 2 :MeOH (1:1 v/v). The combined concentrated extracts, after vacuum liquid chromatography (VLC) and semipreparative reverse-phase HPLC separations, led to the isolation of the two pure compounds shown in Figure 1 .

Compound 1 was isolated as an amorphous white solid. The isotopic distribution observed in the (+)-LRESIMS mass spectrum with four protonated ion [M+Na] + peaks at m/z 830, 832, 834, and 836 in the ratio 3:6:3:1 respectively, showed the presence of two bromine atoms and a chlorine atom in the molecule. The presence of these halogens in the structure was confirmed by (+)-HRESI-TOFMS analysis, with the ion peak observed at m/z 830.0400 [M+Na] + corresponding to the molecular formula C 25 Figure 2 ). Both amino acids were directly connected based on the HMBC correlation of the NH signals at δ H 9.11 for Dap1 and δ H 7.72 for Dap2 with the same carbonyl carbon at δ C 169.5. The next amino acid present in the peptide core was an isoserine with a methylene group at δ H 2.75, 3.47/δ C 42.8, a methine carbon at δ H 4.13/δ C 67.8, and an NH signal at δH 8.23. Isoserine was linked to the Dap2 by the correlation between NH at δ H 8.23 and the carbonyl carbon of Dap2 at δ C 170.6. In addition, an HMBC correlation of the methine carbon at δ H 4.13 and the NH signal at δ H 7.13, which belongs to a unit of isoasparagine (δ H 4.58/δ C 48.4, δ H 2.80, 3.09/δ C 35.0), with the carbonyl group at δ C 170.6 allowed the sequence of amino acids to be continued. Finally, the peptide ring was closed by an NMe-histidine (δ H 3.99/δ C 65.6, δ H 3.05/δ C 25.0), whose N-methyl group showed an HMBC correlation with carbons belonging to the carbonyl group of iAsn at δ C 173.5 and its own methine at δ C 65.6, with an additional HMBC correlation between the α-aminoacid proton signal of NMe-histidine and the NH signal at δ H 9.11 of Dap1 with the carbonyl carbon at δ C 169.0 ( Figure 2 ). NMe-histidine ring shifts at δ C 110.5, δ C 128.2, and δ H 6.76/δ C 109.5 revealed that the non-protonated carbon at δ C 128.2 bore one of the three halogen atoms. To complete the structure elucidation, the two remaining doublets with a small coupling constant value of 2.7 Hz were assigned to an sp 2 methine at δ H 6.30/δ C 110.4 and a significant downfield NH signal at δ H 12.68. An HMBC correlation of these two protons with three non-protonated sp 2 carbons (δ C 96.9, 118.1, and 123.2), demonstrated the existence of a trisubstituted pyrrol moiety, with two of these three positions bearing halogens. The placement of this heterocycle was established by the HMBC correlation of the methylene group of Dap2 with a carbonyl group at δ C 158.6. To confirm the direct connection between the pyrrol moiety and this carbonyl group, a new gHMBC experiment with J = 3 Hz was conducted. The position of the sp 2 methine in the pyrrol unit and the bond to the ring with the cyclopeptide was settled by the HMBC correlation between the methine proton at δ H 6.30 and the carbonyl group at δ C 158.6. Although the chlorine and two bromine atoms were undoubtedly located on the three free positions of the heterocycle ring and the carbon shifts (δ C 96.9 and 123.2) suggested that both bromine atoms were on the pyrrol moiety, this evidence was insufficient to fully confirm this proposal. Fortunately, this could be resolved by detailed study of the peptide structure by (+)-HRESI-TOFMS and QTOFMS (Figure 3) , which showed significant cluster ions at m/z 158.0487/160.0460 in a 3:1 ratio corresponding to the iAsn moiety. These m/z values, the mass error observed, and the isotopic distribution clearly confirmed the presence of a chlorine atom on the NMeHis amino acid ( Figure S30 ). [23] . The sequencing for compound 2 was carried out using a combination of HMBC and ROESY data. Long-range correlations from α-protons, NH, and NMe to carbonyl carbons of adjacent amino acids plus ROESY correlations between α-protons, NH, and NMe protons of adjacent amino acids (see Figure 2 ) allowed us to establish the sequence as Br 3 Py-Ile-NMeLeu-Pro-Gln. The absolute configurations of the amino acids were determined by comparing the hydrolysis products of 2 (6 N HCl, 110 • C, 18 h) after derivatization with Marfey's reagent (N-(3-fluoro-4,6-dinitrophenyl)-l-alaninamide, l-FDAA), with appropriate amino acid standards using HPLC-MS chromatography. As a result, all the amino acids were determined to be L.

Optical rotations were determined using a Jasco P-1020 polarimeter. UV spectra were performed using an Agilent 8453 UV−vis spectrometer. IR spectra were obtained with a Perkin-Elmer Spectrum 100 FT-IR spectrometer with ATR sampling. NMR spectra were recorded on a Varian "Unity 500" spectrometer at 500/125 MHz ( 1 H/ 13 C). Chemical shifts were reported in ppm using residual CD 3 OH (δ 3.31 ppm for 1 H and 49.0 ppm for 13 C) and DMSO-d 6 (δ 2.50 ppm for 1 H and 39.5 ppm for 13 C) as an internal reference.

HRESI-TOFMS was performed on an Agilent 6230 TOF LC/MS chromatograph spectrometer. (+)-ESIMS were recorded using an Agilent 1100 Series LC/MSD spectrometer. HRESI-TOFMS was performed on an Agilent 6230 TOF LC/MS chromatograph spectrometer. ESI(+) and MS e were performed on an Waters UHPLC-QTOF Acquity I-Class + Xevo G2-XS.

The sponge Ircinia sp. (158 g) was collected by hand using a diving rebreather system in the Thousand Islands (Indonesia). The sponge was immediately frozen and kept under these conditions until extraction. The specimen was identified by María Jesús Uriz at CEAB, Blanes, Spain. A voucher specimen (ORMA155272) was deposited at PharmaMar facilities (Madrid, Spain).

The sponge Ircinia sp. (158 g) was triturated and exhaustively extracted with MeOH:DCM (1:1, 3 × 500 mL). The combined extracts were concentrated to yield a crude mass of 7.9 g. The crude product was subjected to VLC on a Lichroprep RP-18 with a stepped gradient from H 2 O to MeOH to CH 2 

Absolute Configuration of 1. First, 0.5 mg of haloirciniamide A was hydrolyzed in 0.5 mL of 6 N HCl at 110 • C for 15 h. The excess aqueous HCl was removed under a N 2 stream, and a solution of 700 µg of l-FDAA (N-(3-fluoro-4,6-dinitrophenyl)-l-alanine-amide) in acetone (160 µL), H 2 O (100 µL), and NaHCO 3 1N (50 µL) was added to the dry hydrolysate. The resulting mixture was heated at 40 ºC for 1 h, before being cooled to 23 ºC, quenched by addition of 2N HCl (20 µL), dried, and dissolved in H 2 O (800 µL). The resultant aqueous solution was subjected to reversed-phase LC/MS (column: Waters Symmetry 4.6 × 150 mm, 3.5 µm, flow rate 0.8 mL/min) in three different gradients. Gradient 1 for iSer (mobile phase CH 3 CN + 0.04% formic acid /H 2 O + 0.04% formic acid, using a linear gradient from 5% to 20% CH 3 CN in 10 min and then from 20% to 35% CH 3 CN in 25 min): the retention time was 23.9 min for l-iSer.

Gradient 2 for Asp (mobile phase CH 3 CN + 0.04% formic acid/H 2 O + 0.04% formic acid, using a linear gradient from 5% to 30% CH 3 CN in 10 min and then from 30% to 50% CH 3 CN in 30 min): the retention time was 17.0 min for d-Asp.

Gradient 3 for Dap: mobile phase CH 3 CN + 0.04% formic acid/H 2 O + 0.04% formic acid, using a linear gradient from 5% to 10% CH 3 CN in 5 min and then from 10% to 35% CH 3 CN in 25 min): the retention times was 15.5 min for l-Dap.

Retention times for the derivatized amino acids standards were as follows: gradient 1 (23. 

The cytotoxic activity of 1 and 2 was tested against four human tumor cell lines, lung (A-549), colon (HT-29), breast (MDA-MB-231), and pancreas PSN-1, and both compounds displayed a GI 50 > 1.2 × 10 −5 M in all cell lines. Since these compounds did not show cytotoxicity, we further evaluated an anticancer response through other targets. Thus, compound 1 was further tested for the capacity to inhibit the enzyme topoisomerase I, but it showed no inhibition of the enzyme at 1.0 × 10 −5 M, and therefore, it was not considered active in inhibiting this enzyme. Likewise, compounds 1 and 2 were unable to impair the interaction between the programmed cell death protein PD-1 and its natural ligand PDL1 as demonstrated by their lack of effect in a cell-based assay whose final readout was dependent on the interaction between the two proteins (Table 3) . Table 3 . % PD-1 and TOPO-I inhibition for compounds 1 and 2. PD-1: programmed cell death protein.

Target %Inhibition at 1 × 10 −5 M 1  Top-I  3  1 PD-1 0.3 2 PD-1 −3.5

In summary, two new peptides bearing unprecedented halogenated moieties, haloirciniamide A (1) and seribunamide A (2), were isolated from a marine sponge belonging to the Irnicia genus, which was selected for further studies. The sample was collected around the Thousand Islands (Indonesia) by the Pharmamar expedition team in collaboration with the Research Center for Oceanography, Indonesian Institute of Sciences (RCO-LIPI). The planar structures of the novel compounds were determined by a combination of extensive NMR and HPLC-MS experiments. The absolute configuration was achieved by Marfey's analysis after acid hydrolysis. Cytotoxic activity in the four cancer cell lines tested was not observed for 1 and 2, as in the case of gunungamide A and cyclocinamide B. In addition, an anticancer immune response was also evaluated, and neither compound was able to impair PD1-PDL1 interaction. Moreover, compound 1 failed to inhibit the enzyme topoisomerase I. Unfortunately, the amount of the compounds isolated was not enough for further assays. This work is the first example of the isolation and structural elucidation of novel compounds with unique structural features from an Ircinia sponge, which highlights this gender and its microbiota as a distinctive source of novel structures. 

Marine Natural Products from Indonesian Waters

Marine Sponge Derived Natural Products between 2001 and 2010: Trends and Opportunities for Discovery of Bioactives

Structure of a novel multidrug resistance modulator, irciniasulfonic acid, isolated from a marine sponge Ircinia sp

Sterols from the sponges Ircinia pipetta and Dysidea avara identification of cholestatrienol

A new epoxy sterol from the sponge Ircinia fasciculata

New cytotoxic furanosesterterpenes from an Okinawan marine sponge Ircinia sp

New scalarane sesterterpenoids from the Formosan sponge Ircinia felix

New chondropsin macrolide lactams from marine sponges in the genus Ircinia

Tedanolide C: A potent new 18-membered-ring cytotoxic macrolide isolated from the Papua New Guinea marine sponge Ircinia sp

Polydiscamides B−D from a marine sponge Ircinia sp. as potent human sensory neuron-specific G protein coupled receptor agonists

Monitoring Bacterial Diversity of the Marine Sponge Ircinia strobilina upon Transfer into Aquaculture

Cyclic Hexapeptide from the Sponge Ircinia dendroides

Cyclotheonamide E4 and E5, New Potent Tryptase Inhibitors from an Ircinia Species of Sponge

New Lipopeptides from the Caribbean Cyanobacterium Lyngbya majuscula

New Jaspamide Derivatives from the Marine Sponge Jaspis splendens

New Cyclic Peptides from the Ascidian Lissoclinum patella

Isolation and structure of a peptide toxin from the marine snail Conus magus

The isolation and structure of a remarkable marine animal antineoplastic constituent: Dolastatin 10

Halogenanted Cyclic Peptides Isolated from the Sponge Corticium sp

Combining JBCA and Marfey's methodology to determine the absolute configuration of threonines: The case of gunungamide A, a new cyclic depsideptide containing chloropyrrole from the sponge Discodermia sp

Bromopyrrole Alkaloids from Marine Sponges of the Genus Agelas

Carteramine A, an inhibitor of neutrophil chemotaxis, from the marine sponge Stylissa carteri

2,3,4-Tribromopyrrole from the marine Polychaete Polyphysia crassa

A Coralline Algal-Associated Bacterium

Use of a bifunctional reagent, 1,5-difluoro-2,4-dinitro-benzene

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license

We gratefully acknowledge the help of our PharmaMar colleagues C. Crespo for her excellent technical assistance, E. Millán for performing the ESI(+) and MS e experiments, J. M. Dominguez for the biological assays and S. Munt for revision of the manuscript.

The authors declare no conflict of interest.